Categories

  • Actos Manufacturers Pay Billions in Damages
    Actos is one of the best-known diabetes medications for a reason—it works. For years, doctors prescribed it to treat diabetes because its key ingredient, pioglitazone, decreased the amount of glucose released by the liver. In combination with other treatments, Actos helped diabetes patients better regulate their blood sugar levels. Yet despite how well the medication works, a dangerous side effect...
  • FDA Issues Warnings Regarding Newly Discovered Invokana® Side Effects
    Invokana® is a medication approved by the U.S. Food and Drug Administration (FDA) in 2013 for the treatment of Type II diabetes. But research has shown the drug may have serious adverse effects on some users’ health. Some Invokana side effects may include: Ketoacidosis Renal failure Fungal infections Low blood Pressure Stroke Tissue decomposition Coma These aren’t the only risks associated...
  • Actos® Bladder Cancer Settlement Moves Forward
    In May, Takeda Pharmaceuticals, Inc., the maker of Actos®, offered to settle thousands of bladder cancer lawsuits for $2.4 billion. Here’s a link to a previous post we made in May about the settlement. When the offer was made earlier this year, victims still needed to agree to the terms of the settlement before it could be finalized. Now, a...
  • Drug-Induced Heart Attack Risks
    Some drugs pose more serious and threatening side effects than others—including heart attacks. Kidney Dialysis Products The U.S. Food and Drug Administration (FDA) reports that there were an estimated 1,000 heart attacks as the result of using Fresenius Medical Care’s Granuflo® or Naturalyte® products in 2010 alone. Use of the product can cause a patient to suffer from a condition...
  • Are We Getting the Whole Story When it Comes to Drug Safety?
    The results of drug safety tests are often published in peer-reviewed medical journals. But do these publications provide doctors and patients with enough information? Some experts say no. An article from Salon examines the numerous medication safety studies conducted annually in the U.S. and found only a handful of results get published. Safety findings regarding antidepressants are highlighted as an...
  • $200 Million Settlement Approved for 2012 Fungal Meningitis Outbreak
    The U.S. Food and Drug Administration creates policies that regulate the manufacturing of medications to ensure patient safety. But many companies fail to adhere to these rules, resulting in innocent people being harmed. One such case was the fungal meningitis outbreak of 2012 that claimed the lives of dozens of Tennesseans and left hundreds of others sickened. A Boston-based company,...
FREE CASE REVIEW